Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy

Open access
Chen, Hong-Xu, Liang, Fu-Chao, Gu, Ping, Xu, Bian-Ling, Xu, Hong-Jun, Wang, Wen-Ting, Hou, Jia-Yang, Xie, Dong-Xiao, Chai, Xi-Qing, An, Sheng-Jun · 2020 · Cell Death & Disease

Abstract

Parkinson’s disease (PD) is a progressively debilitating neurodegenerative condition that leads to motor and cognitive dysfunction. At present, clinical treatment can only improve symptoms, but cannot effectively protect dopaminergic neurons. Several reports have demonstrated that human umbilical cord mesenchymal stem cells (hucMSCs) afford neuroprotection, while their application is limited because of their uncontrollable differentiation and other reasons. Stem cells communicate with cells through secreted exosomes (Exos), the present study aimed to explore whether Exos secreted by hucMSCs could function instead of hucMSCs. hucMSCs were successfully isolated and characterized, and shown to contribute to 6-hydroxydopamine (6-OHDA)-stimulated SH-SY5Y cell proliferation; hucMSC-derived Exos were also involved in this process. The Exos were purified and identified, and then labeled with PKH 26, it was found that the Exos could be efficiently taken up by SH-SY5Y cells after 12 h of incubation. Pretreatment with Exos promoted 6-OHDA-stimulated SH-SY5Y cells to proliferate and inhibited apoptosis by inducing autophagy. Furthermore, Exos reached the substantia nigra through the blood–brain barrier (BBB) in vivo, relieved apomorphine-induced asymmetric rotation, reduced substantia nigra dopaminergic neuron loss and apoptosis, and upregulated the level of dopamine in the striatum. These results demonstrate that hucMSCs-Exos have a treatment capability for PD and can traverse the BBB, indicating their potential for the effective treatment of PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-020-2473-5

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Typical features of hucMSCs. a Morphological appearance of hucMSCs. The appearance and growth of hucMSCs colonies after 6 days of culturing (left); after replating the cells took on the appearance of long spindle-shaped fibroblastic cells, began to form colonies and became confluent (right). b Growth curve of hucMSCs. The cells grew logarithmically from day 2, and on the third day the growth rate slowed because of the replacement of culture medium. c The surface antigens of hucMSCs. The cells were positive for CD90, CD105, CD73 expression and negative for CD34, CD45, and HLA-DR. d Results of Oil red O, Alizarin Red, and Alcian Blue detection in cell cultures growing after 3 weeks. Control cells grew in regular medium.
Fig. 1 Typical features of hucMSCs. a Morphological appearance of hucMSCs. The appearance and growth of hucMSCs colonies after 6 days of culturing (left); after replating the cells took on the appearance of long spindle-shaped fibroblastic cells, began to form colonies and became confluent (right). b Growth curve of hucMSCs. The cells grew logarithmically from day 2, and on the third day the growth rate slowed because of the replacement of culture medium. c The surface antigens of hucMSCs. The cells were positive for CD90, CD105, CD73 expression and negative for CD34, CD45, and HLA-DR. d Results of Oil red O, Alizarin Red, and Alcian Blue detection in cell cultures growing after 3 weeks. Control cells grew in regular medium.CC BY · PubMed Central
Fig. 2 6-OHDA-stimulated SH-SY5Y cell viability. CCK-8 was used to measure SH-SY5Y cell viability after exposure to 50, 75, 100, 125, and 150 µM 6-OHDA for 6 h, 12 h, 18 h, and 24 h. All data represent mean values ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 vs 0 µM 6-OHDA (n = 4).
Fig. 2 6-OHDA-stimulated SH-SY5Y cell viability. CCK-8 was used to measure SH-SY5Y cell viability after exposure to 50, 75, 100, 125, and 150 µM 6-OHDA for 6 h, 12 h, 18 h, and 24 h. All data represent mean values ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 vs 0 µM 6-OHDA (n = 4).CC BY · PubMed Central
Fig. 3 The function and typical characteristics of Exos. a The transwell system. hucMSCs and 6-OHDA-stimulated SH-SY5Y cells were co-cultured in a transwell system. GW4869 was used at a concentration of 10 µM to reduce the release of Exos from hucMSCs. After co-culturing for 8 h, the viability of 6-OHDA-stimulated SH-SY5Y cells was determined (n = 4). b Representative transmission electron microscopy (TEM) images of Exos. Scale bar, 100 nm. Size distributions of Exos were measured using nanoparticle tracking analysis (NTA). Western blotting analysis of Exos markers including CD9, CD63, Tsg101, and Calnexin. c PKH26-labeled Exos (red) and DAPI (blue). Arrows indicate Exos. All data represent mean values ± SD. *P < 0.05; **P < 0.01; ***P < 0.001.
Fig. 3 The function and typical characteristics of Exos. a The transwell system. hucMSCs and 6-OHDA-stimulated SH-SY5Y cells were co-cultured in a transwell system. GW4869 was used at a concentration of 10 µM to reduce the release of Exos from hucMSCs. After co-culturing for 8 h, the viability of 6-OHDA-stimulated SH-SY5Y cells was determined (n = 4). b Representative transmission electron microscopy (TEM) images of Exos. Scale bar, 100 nm. Size distributions of Exos were measured using nanoparticle tracking analysis (NTA). Western blotting analysis of Exos markers including CD9, CD63, Tsg101, and Calnexin. c PKH26-labeled Exos (red) and DAPI (blue). Arrows indicate Exos. All data represent mean values ± SD. *P < 0.05; **P < 0.01; ***P < 0.001.CC BY · PubMed Central
Fig. 4 Exos enhanced SH-SY5Y cell viability and reduced SH-SY5Y cell apoptosis. a Cell viability was assessed by CCK-8, n = 4. b Western blotting was used to detect 6-OHDA-induced changes in apoptosis-related proteins, n = 4. c 6-OHDA-stimulated SH-SY5Y cell apoptosis was tested by FCM. All data represent mean values ± SD. n = 3. *P < 0.05; **P < 0.01; ***P < 0.001.
Fig. 4 Exos enhanced SH-SY5Y cell viability and reduced SH-SY5Y cell apoptosis. a Cell viability was assessed by CCK-8, n = 4. b Western blotting was used to detect 6-OHDA-induced changes in apoptosis-related proteins, n = 4. c 6-OHDA-stimulated SH-SY5Y cell apoptosis was tested by FCM. All data represent mean values ± SD. n = 3. *P < 0.05; **P < 0.01; ***P < 0.001.CC BY · PubMed Central
Fig. 5 Exos increased the level of 6-OHDA-stimulated SH-SY5Y cell autophagy. a Western blotting was used to detect 6-OHDA-induced changes in autophagy proteins. b Autolysosomes and autophagosomes were detected by tandem fluorescent GFP-RFG- LC3 assay. c Autophagosomes were measured by TEM in four groups. All data represent mean values ± SD. *P < 0.05; **P < 0.01 (n = 4).
Fig. 5 Exos increased the level of 6-OHDA-stimulated SH-SY5Y cell autophagy. a Western blotting was used to detect 6-OHDA-induced changes in autophagy proteins. b Autolysosomes and autophagosomes were detected by tandem fluorescent GFP-RFG- LC3 assay. c Autophagosomes were measured by TEM in four groups. All data represent mean values ± SD. *P < 0.05; **P < 0.01 (n = 4).CC BY · PubMed Central
Fig. 6 The accumulation of Exos in the SN of brain tissue in the PD rat model; Exos improved the behavioral deficits of PD model rats. a Experimental protocol schematic in vivo. b PKH67-labeled Exos were intravenously injected into rats. The co-location of Saline and Exos (green) with dopaminergic neurons in the SN of brain tissue. TH (red) indicates dopaminergic neurons. DAPI identified cell nuclei, n = 3. c APO-induced asymmetric rotation in PD model rats was relieved for 8 weeks after transplantation with Exos. APO-induced rotation in the 6-OHDA+Saline group and 6-OHDA+ Exos group. TH: Tyrosine hydroxylase. Arrows indicate Exos. All data represent mean values ± SD. **P < 0.01 vs 6-OHDA+Saline group, ##P < 0.01 vs 0 week, $$P < 0.01 vs 4 weeks (n = 8).
Fig. 6 The accumulation of Exos in the SN of brain tissue in the PD rat model; Exos improved the behavioral deficits of PD model rats. a Experimental protocol schematic in vivo. b PKH67-labeled Exos were intravenously injected into rats. The co-location of Saline and Exos (green) with dopaminergic neurons in the SN of brain tissue. TH (red) indicates dopaminergic neurons. DAPI identified cell nuclei, n = 3. c APO-induced asymmetric rotation in PD model rats was relieved for 8 weeks after transplantation with Exos. APO-induced rotation in the 6-OHDA+Saline group and 6-OHDA+ Exos group. TH: Tyrosine hydroxylase. Arrows indicate Exos. All data represent mean values ± SD. **P < 0.01 vs 6-OHDA+Saline group, ##P < 0.01 vs 0 week, $$P < 0.01 vs 4 weeks (n = 8).CC BY · PubMed Central
Fig. 7 Exos significantly reduced SN dopaminergic neurons loss and apoptosis in the PD rat model. a Detection of tissue damage in the SN lesioned side by H&E staining. b SN sections from each rat were analyzed for the dopaminergic neuron counts by TH immunohistochemistry. Ventral midbrain images show the 6-OHDA lesioned side (right) compared with the unlesioned side (left). c Lesion severity assessed by dopaminergic neurons counts was significantly reduced in the 6-OHDA+ Exos group. d Representative SN section stained for the dopaminergic neuronal marker TH (red) and subjected to TUNEL assay (green) to visualize apoptosis. Nuclei of the cells are counterstained with DAPI (blue). Images were collected on the fluorescence microscopy. The arrows show significantly increased expression of TUNEL staining in the nucleus of neurons. e Quantitative analysis of Exos-induced protection as measured by TUNEL+/TH+ staining produced a significant neuroprotective effect. All data represent mean values ± SD. ***P < 0.001, **P < 0.01 (n = 4).
Fig. 7 Exos significantly reduced SN dopaminergic neurons loss and apoptosis in the PD rat model. a Detection of tissue damage in the SN lesioned side by H&E staining. b SN sections from each rat were analyzed for the dopaminergic neuron counts by TH immunohistochemistry. Ventral midbrain images show the 6-OHDA lesioned side (right) compared with the unlesioned side (left). c Lesion severity assessed by dopaminergic neurons counts was significantly reduced in the 6-OHDA+ Exos group. d Representative SN section stained for the dopaminergic neuronal marker TH (red) and subjected to TUNEL assay (green) to visualize apoptosis. Nuclei of the cells are counterstained with DAPI (blue). Images were collected on the fluorescence microscopy. The arrows show significantly increased expression of TUNEL staining in the nucleus of neurons. e Quantitative analysis of Exos-induced protection as measured by TUNEL+/TH+ staining produced a significant neuroprotective effect. All data represent mean values ± SD. ***P < 0.001, **P < 0.01 (n = 4).CC BY · PubMed Central
Fig. 8 Exos upregulated the levels of DA and its metabolites in the striatum of the PD rat model. a Chemical structures of the analyte. b HPLC-MS was used to measure DA, DOPAC, and HVA levels. Exos significantly reversed 6-OHDA-downregulated DA, DOPAC, and HVA levels. All data represent mean values ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 (n = 3).
Fig. 8 Exos upregulated the levels of DA and its metabolites in the striatum of the PD rat model. a Chemical structures of the analyte. b HPLC-MS was used to measure DA, DOPAC, and HVA levels. Exos significantly reversed 6-OHDA-downregulated DA, DOPAC, and HVA levels. All data represent mean values ± SD. *P < 0.05; **P < 0.01; ***P < 0.001 (n = 3).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Cited by

See all 327

Metadata

Authors
Chen, H.-X., Liang, F.-C., Gu, P., Xu, B.-L., Xu, H.-J., Wang, W.-T., Hou, J.-Y., Xie, D.-X., Chai, X.-Q., & An, S.-J.
Affiliations
  • Hebei Medical University (CN)
  • Hebei University of Chinese Medicine (CN)
  • Second Hospital of Hebei Medical University (CN)
Corresponding author
Chai, Xi-Qing
Venue
Cell Death & Disease
Published
2020-04-27
Volume
11
Issue
4
Pages
288-288
ISSN
2041-4889 (ISSN-L)
OpenAlex
W3018217038
Cited by
319
References
68
Citations by year
2026: 42 · 2025: 58 · 2024: 66 · 2023: 59 · 2022: 53 · 2021: 33 · 2020: 8
FWCI
12.41
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Natural Science Foundation of Hebei Province (18967728D)
  • National Natural Science Foundation of China (81873230)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
Parkinson's disease, exosomes, mesenchymal stem cells, human umbilical cord mesenchymal stem cells, autophagy, dopaminergic neuroprotection, 6-hydroxydopamine, SH-SY5Y cells, substantia nigra, blood-brain barrier, neuroprotection, apoptosis, dopamine
MeSH terms
Animals, Autophagy, Blood-Brain Barrier, Cell Differentiation, Humans, Parkinson Disease, Mice, Exosomes, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy. https://app.cochat.ai/papers/10.1038/s41419-020-2473-5
The paper
Chen, H.-X., Liang, F.-C., Gu, P., Xu, B.-L., Xu, H.-J., Wang, W.-T., Hou, J.-Y., Xie, D.-X., Chai, X.-Q., & An, S.-J. (2020). Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy. Cell Death & Disease. https://doi.org/10.1038/s41419-020-2473-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.